Image (B60d626b A3ab 45a0 9abc Cce73f2039da 283 2)
Prasugrel Tablet, Film Coated
Product Images NDC 29300-301
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 29300-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 01)
A line graph comparing the percentage of non-CABG-related TIMI major or minor bleeding events over days from randomization for Prasugrel and Clopidogrel. The graph shows time on the x-axis and bleeding event percentage on the y-axis, with separate curves for each drug and a smaller inset graph highlighting early time points. Numbers at risk for each drug are indicated below the x-axis.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 02)
Chemical structure of Prasugrel hydrochloride, showing molecular connectivity with oxygen, nitrogen, sulfur, fluorine atoms and a cyclopropyl group in its chemical framework.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 03)
A line graph showing the inhibition of platelet aggregation (%) over time (hours) after administration of Prasugrel tablets. The graph plots mean values with standard deviation error bars, indicating the level of platelet aggregation inhibition up to 24 hours.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 04)
A Kaplan-Meier curve comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke over days from randomization between Prasugrel and Clopidogrel in UA/NSTEMI patients. The graph shows a lower event rate for Prasugrel compared to Clopidogrel, with p-values of 0.002 and 0.017 indicated.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 05)
A line graph depicting cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke percentage over days from randomization in a study. It compares the outcomes between Prasugrel and Clopidogrel treatments in STEMI patients, with Prasugrel showing a lower event rate. The graph includes a significance marker (p=0.02) and an inset zoomed-in view with stricter significance (p=0.008).*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 06)
A forest plot figure showing baseline patient characteristics and hazard ratios comparing the effect of prasugrel tablets versus clopidogrel. It includes categories such as age, gender, body weight, region, diabetes and metabolic syndrome status, previous medical history, and other factors, with corresponding percent events and graphical hazard ratio markers indicating which treatment is favored.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 07)
A forest plot chart presenting baseline characteristics and subgroup analyses comparing the hazard ratio between prasugrel tablets and clopidogrel. It includes categories such as age, gender, body weight, region, diabetes status, previous medical history, and medication use, with hazard ratios visually depicted on a logarithmic scale indicating which treatment is favored.*
Container Label (C00bf751 5fbd 4cae 9262 63fd9f0b372a 08)
Prasugrel Tablets, USP 5 mg film-coated tablets in a 30-count unit-of-use bottle. The label includes the NDC number 29300-301-13, dispensing instructions, and manufacturer details for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), Inc. The label also includes storage instructions and a barcode.*
Container Label (C00bf751 5fbd 4cae 9262 63fd9f0b372a 09)
Prasugrel Tablets USP 10 mg film-coated tablets label. The label states the dosage strength as 10 mg, indicates the tablets are for oral administration, and mentions a package size of 30 tablets. It includes directions to dispense and keep in the original container, manufacturer details for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), and the NDC number 29300-302-13.*
Image (C00bf751 5fbd 4cae 9262 63fd9f0b372a 261 1)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
